ctrl K

Price Alert

Madrigal Pharmaceuticals ... (MDGL)

NASDAQ: MDGL · Real-Time Price · USD

363.59

-7.78 (-2.09%)

At close: Aug 15, 2025, 2:56 PM

Madrigal Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	100.02M	99.92M	331.55M	36.27M
Short-Term Investments	826.23M	534.22M	27.23M	234.08M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a
Receivables	53.82M	n/a	n/a	n/a
Inventory	34.07M	n/a	n/a	n/a
Other Current Assets	18.79M	3.15M	2.6M	1.34M
Total Current Assets	1.03B	637.28M	361.37M	271.68M
Property-Plant & Equipment	4.59M	3.27M	1.2M	1.65M
Goodwill & Intangibles	4.73M	n/a	n/a	n/a
Total Long-Term Assets	9.32M	3.27M	1.2M	1.65M
Total Assets	1.04B	640.55M	362.57M	273.33M
Account Payables	43.6M	28.04M	23.83M	21.38M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	983K	n/a	n/a	n/a
Other Current Liabilities	89.74M	72.95M	n/a	6.77M
Total Current Liabilities	169.28M	118.55M	115.89M	76.84M
Long-Term Debt	117.57M	115.48M	49.29M	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	118.59M	116.67M	49.29M	387K
Total Liabilities	287.86M	235.21M	165.18M	77.22M
Total Debt	119.57M	117.19M	49.89M	797K
Common Stock	2K	2K	2K	2K
Retained Earnings	-1.8B	-1.34B	-962.66M	-667.31M
Comprehensive Income	468K	468K	-32K	-80K
Shareholders Equity	754.38M	405.33M	197.39M	196.11M
Total Investments	826.23M	534.22M	27.23M	234.08M